ImmRNA: a Database of RNAs Associated with Tumor Immunity

Overview

Journal Database (Oxford)

Specialty Biology

Date 2024 Jul 6

PMID 38970503

Authors

Fangfang Shen

Zelian Li

Pengfei Wu

Jinpeng Wang

Affiliations

Soon will be listed here.

Abstract

The relationship between different ribonucleic acids (RNAs) and tumor immunity has been widely investigated. However, a systematic description of tumor immune-related RNAs in different tumors is still lacking. We collected the relationship of tumor immune-related RNAs from the published literature and presented them in a user-friendly interface, "ImmRNA" (http://www.immrna.cn/), to provide a resource to study immune-RNA-cancer regulatory relations. The ImmRNA contains 49 996 curated entries. Each entry includes gene symbols, gene types, target genes, downstream effects, functions, immune cells, and other information. By rearranging and reanalyzing the data, our dataset contains the following key points: (i) providing the links between RNAs and the immune in cancers, (ii) displaying the downstream effects and functions of RNAs, (iii) listing immune cells and immune pathways related to RNA function, (iv) showing the relationship between RNAs and prognostic outcomes, and (v) exhibiting the experimental methods described in the article. ImmRNA provides a valuable resource for understanding the functions of tumor immune-related RNAs. Database URL: http://www.immrna.cn/.

References

Le Dieu R, Taussig D, Ramsay A, Mitter R, Miraki-Moud F, Fatah R . Peripheral blood T cells in acute myeloid leukemia (AML) patients at diagnosis have abnormal phenotype and genotype and form defective immune synapses with AML blasts. Blood. 2009; 114(18):3909-16. PMC: 2773481. DOI: 10.1182/blood-2009-02-206946. View

Smolle M, Prinz F, Calin G, Pichler M . Current concepts of non-coding RNA regulation of immune checkpoints in cancer. Mol Aspects Med. 2019; 70:117-126. DOI: 10.1016/j.mam.2019.09.007. View

Ning S, Zhang J, Wang P, Zhi H, Wang J, Liu Y . Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers. Nucleic Acids Res. 2015; 44(D1):D980-5. PMC: 4702799. DOI: 10.1093/nar/gkv1094. View

Aubert L, Nandagopal N, Steinhart Z, Lavoie G, Nourreddine S, Berman J . Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer. Nat Commun. 2020; 11(1):3701. PMC: 7381612. DOI: 10.1038/s41467-020-17549-y. View

Chen D, Xie J, Fiskesund R, Dong W, Liang X, Lv J . Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype. Nat Commun. 2018; 9(1):873. PMC: 5830447. DOI: 10.1038/s41467-018-03225-9. View

Yu H, Pardoll D, Jove R . STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009; 9(11):798-809. PMC: 4856025. DOI: 10.1038/nrc2734. View

Massimino M, Stella S, Tirro E, Romano C, Pennisi M, Puma A . Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia. Mol Cancer. 2018; 17(1):56. PMC: 5817805. DOI: 10.1186/s12943-018-0805-1. View

Liu Y, Zhou X, Wang X . Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities. J Hematol Oncol. 2021; 14(1):125. PMC: 8369706. DOI: 10.1186/s13045-021-01134-x. View

Zhang D, Shi R, Xiang W, Kang X, Tang B, Li C . The Agpat4/LPA axis in colorectal cancer cells regulates antitumor responses via p38/p65 signaling in macrophages. Signal Transduct Target Ther. 2020; 5(1):24. PMC: 7099097. DOI: 10.1038/s41392-020-0117-y. View

10.

Schmidt L, Spieker T, Koschmieder S, Schaffers S, Humberg J, Jungen D . The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol. 2011; 6(12):1984-92. DOI: 10.1097/JTO.0b013e3182307eac. View

11.

Song K, Li Q, Gao W, Lu S, Shen Q, Liu X . AlloDriver: a method for the identification and analysis of cancer driver targets. Nucleic Acids Res. 2019; 47(W1):W315-W321. PMC: 6602569. DOI: 10.1093/nar/gkz350. View

12.

Dong M, Blobe G . Role of transforming growth factor-beta in hematologic malignancies. Blood. 2006; 107(12):4589-96. PMC: 1895802. DOI: 10.1182/blood-2005-10-4169. View

13.

Wu P, Geng B, Chen Q, Zhao E, Liu J, Sun C . Tumor Cell-Derived TGFβ1 Attenuates Antitumor Immune Activity of T Cells via Regulation of PD-1 mRNA. Cancer Immunol Res. 2020; 8(12):1470-1484. DOI: 10.1158/2326-6066.CIR-20-0113. View